Copper-Based Drug Shows Promise in Reversing Alzheimer's Memory Loss

This breakthrough treatment addresses one of Alzheimer's disease's most devastating symptoms—memory loss—by targeting toxic protein accumulation in the brain. By enabling copper transport to clear amyloid-beta proteins, this drug represents a novel therapeutic approach that could fundamentally transform dementia care. If clinical trials confirm these results, it could open a new avenue for treating neurodegenerative diseases that currently lack effective interventions.